The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab (pembro) plus lenvatinib (lenva) in patients (pts) with docetaxel-pretreated, metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort E.
 
Marinela Augustin
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; IPSEN,; Merck; MSD; Novartis; Pfizer; PharmaMar; Roche
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Immatics (Inst); IPSEN, (Inst); Lilly (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; IPSEN,; Janssen-Cilag; Lilly; Merck; Novartis; Pfizer; PharmaMar
 
Brigitte Laguerre
Honoraria - Astellas Pharma; Bayer; Bayer; Bayer; Eisai; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; MSD Oncology; Pfizer
 
Capucine Baldini
Consulting or Advisory Role - Bicycle Therapeutics; Janssen Oncology; Rising Tide Foundation
Research Funding - Bristol-Myers Squibb
Expert Testimony - Abbvie; Bristol-Myers Squibb
Travel, Accommodations, Expenses - Amgen; MSD Oncology; Roche/Genentech
 
Ahmed H. Zedan
No Relationships to Disclose
 
Enrique Gonzalez-Billalabeitia
Consulting or Advisory Role - AstraZeneca; Bayer; Janssen Oncology
Research Funding - Merck
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Bristol-Myers Squibb; Janssen-Cilag; Pfizer; Pfizer; Roche; Sanofi
 
Peter C.C. Fong
Consulting or Advisory Role - MSD
 
Ruslan Zukov
No Relationships to Disclose
 
Peter Hammerer
No Relationships to Disclose
 
Mark Prentice
No Relationships to Disclose
 
Neal D. Shore
Employment - GenesisCare
Leadership - Alessa Therapeutics; Photocure
Consulting or Advisory Role - Abbvie; AIkido Pharma; Amgen; Arquer Diagnostics; Asieris Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Sanofi; CG Oncology; CG Oncology; Clarity Pharmaceuticals; Clovis Oncology; Dendreon; Exact Imaging; Exact Sciences; FerGene; Ferring; Fize Medical; Foundation Medicine; Genesis Cancer Care; Genzyme; Guardant Health; ImmunityBio; Incyte; InVitae; Janssen Scientific Affairs; Lantheus Medical Imaging; Lilly; MDxHealth; Medivation/Astellas; Merck; Minomic; Myovant Sciences; Myriad Genetics; NGM Biopharmaceuticals; Nonagen Bioscience; Novartis; Nymox; Pacific Edge Biotechnology; Peerview; Pfizer; Phosphorus; Photocure; PlatformQ Health; Profound Medical; Promaxo; Propella Therapeutics; Protara Therapeutics; Sanofi; Sesen Bio; Speciality Networks; Telix Pharmaceuticals; Tempus; Tolmar; Urogen pharma; Vaxiion; Vessi Medical
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; Dendreon; Foundation Medicine; Guardant Health; Janssen; Merck; Pfizer
Research Funding - Abbvie; Advantagene; Amgen; Aragon Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Pfizer; CG Oncology; Clovis Oncology; Dendreon; DisperSol; Endocyte; Exact Imaging; Exelixis; Ferring; FKD Therapies; FORMA Therapeutics; Foundation Medicine; Genentech; Guardant Health; InVitae; Istari Oncology; Janssen; Jiangsu Yahong Meditech; MDxHealth; Medivation; Merck; MT Group; Myovant Sciences; Myriad Genetics; Novartis; Nymox; OncoCellMDx; ORIC Pharmaceuticals; pacific edge; Palette Life Sciences; Pfizer; Plexxikon; POINT Biopharma; Propella Therapeutics; Propella Therapeutics; RhoVac; Sanofi; SeaGen; Sesen Bio; Steba Biotech; Theralase; Tolmar; Urogen pharma; Urotronic; US Biotest; Vaxiion; Veru; Zenflow
Expert Testimony - Ferring
Other Relationship - Alessa Therapeutics; Photocure
 
Andrea Necchi
Employment - Bayer (I)
Stock and Other Ownership Interests - Bayer (I)
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Foundation Medicine; Janssen; Merck; Roche
Consulting or Advisory Role - AstraZeneca; Basilea Pharmaceutical; Bayer; Bristol-Myers Squibb; Catalym; Clovis Oncology; GlaxoSmithKline; Incyte; Janssen; Merck Sharp & Dohme; Rainier Therapeutics; Roche; Seattle Genetics/Astellas
Research Funding - AstraZeneca (Inst); Gilead Sciences; Ipsen; Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Merck Sharp & Dohme; Pfizer; Rainier Therapeutics; Roche
Other Relationship - Bayer (I)
 
Tilman Todenhöfer
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca/Merck; Bayer; Bristol-Myers Squibb/Sanofi; Janssen; Merck Serono; MSD Oncology; Pfizer; Roche; Sanofi/Aventis
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Basilea (Inst); Bayer (Inst); Immunomedics (Inst); Janssen (Inst); Lilly (Inst); MSD Oncology (Inst); Pfizer (Inst); RhoVac (Inst)
 
Elizabeth R. Kessler
Speakers' Bureau - Targeted Oncology
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck Serono (Inst); Pfizer (Inst)
 
Fatih Köse
Honoraria - Astellas Pharma (Inst); AstraZeneca (Inst); Deva (Inst); GlaxoSmithKline (Inst); Janssen (Inst); MSD/Merck (Inst); Nobelpharma (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Deva; GlaxoSmithKline; Janssen; MSD/Merck; Nobelpharma; Novartis; Pfizer; Roche; Takeda
 
Howard Gurney
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Merck Serono; Merck Sharp & Dohme; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Merck Serono
 
Begona Perez Valderrama
No Relationships to Disclose
 
Pengfei Zhu
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Kentaro Imai
Employment - Merck
Stock and Other Ownership Interests - Merck
 
yingjie liu
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Raymond S. McDermott
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Clovis Oncology; Ipsen; Janssen; Merck Sharp & Dohme; Novartis; Pfizer; Sanofi
Speakers' Bureau - MSD Oncology
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Ipsen; Janssen-Cilag; Pfizer; Roche